In summary, the patients with HbA1c ≥ 7.0 had higher baseline fasting blood glucose levels; higher SYNTAX scores; and higher prevalence of PVD, baseline HbA1c ≥ 7.0, and insulin uptake; however, these patients had lower prevalence of hypertension, dyslipidemia, prior stroke, hyperuricemia, single-vessel disease, sulfonylurea uptake, and thiazolidinedione uptake. This evidence concerns the gene INS and Stroke.